HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clayton Smith Selected Research

Granulocyte Colony-Stimulating Factor (G-CSF)

1/2009Pharmacokinetics and pharmacodynamics of plerixafor in patients with non-Hodgkin lymphoma and multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Clayton Smith Research Topics

Disease

8Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2021 - 10/2016
5Leukemia
02/2019 - 08/2003
4Hematologic Neoplasms (Hematological Malignancy)
01/2020 - 01/2003
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2013 - 08/2003
3Graft vs Host Disease (Graft-Versus-Host Disease)
07/2008 - 12/2003
2COVID-19
02/2022 - 03/2021
2Cytopenia
01/2021 - 01/2003
2Prostatic Neoplasms (Prostate Cancer)
01/2020 - 01/2019
1Heart Failure
01/2022
1Severe Acute Respiratory Syndrome
04/2021
1Infections
03/2021
1Rectal Neoplasms (Rectal Cancer)
12/2020
1Cutaneous Fistula
01/2020
1Inborn Genetic Diseases (Disease, Hereditary)
01/2020
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2019
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2018
1Colorectal Neoplasms (Colorectal Cancer)
11/2017
1Bronchiolitis Obliterans Syndrome
11/2017
1Neoplasms (Cancer)
10/2016
1Disease Progression
01/2016
1Wounds and Injuries (Trauma)
08/2015
1Splenomegaly
04/2013
1Leukocytosis (Pleocytosis)
04/2013
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2009
1Multiple Myeloma
01/2009
1Blast Crisis (Blast Phase)
08/2003
1Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
01/2003

Drug/Important Bio-Agent (IBA)

5venetoclaxIBA
12/2021 - 12/2018
5Azacitidine (5 Azacytidine)FDA Link
12/2021 - 12/2018
3VaccinesIBA
02/2022 - 03/2021
3Filgrastim (Neupogen)FDA Link
11/2017 - 01/2016
3Pharmaceutical PreparationsIBA
11/2016 - 08/2003
2Amino AcidsFDA Link
02/2019 - 11/2018
2Biomarkers (Surrogate Marker)IBA
11/2017 - 01/2008
2parthenolideIBA
11/2016 - 10/2016
2Proteins (Proteins, Gene)FDA Link
08/2015 - 08/2003
2Cyclosporine (Ciclosporin)FDA LinkGeneric
02/2007 - 12/2003
1TESIBA
01/2022
1Ferritins (Ferritin)IBA
03/2021
1NanovaccinesIBA
03/2021
1Broadly Neutralizing AntibodiesIBA
03/2021
1SARS-CoV-2 spike proteinIBA
03/2021
1Fatty Acids (Saturated Fatty Acids)IBA
12/2020
1Lenalidomide (CC 5013)FDA Link
01/2019
1Aldehyde DehydrogenaseIBA
11/2017
1InterferonsIBA
11/2017
1CollagenIBA
08/2015
1HydrogelsIBA
08/2015
1EnzymesIBA
04/2013
1Oncogene Proteins (Oncogene Protein)IBA
04/2013
1Adenosine DeaminaseIBA
04/2013
1Tyrosine Kinase InhibitorsIBA
04/2013
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2009
1plerixaforFDA Link
01/2009
1SteroidsIBA
12/2003
1Messenger RNA (mRNA)IBA
08/2003
1LAQ824IBA
08/2003
1Hydroxamic Acids (Hydroxamic Acid)IBA
08/2003
1Imatinib Mesylate (Gleevec)FDA Link
08/2003
1Histone Deacetylases (Histone Deacetylase)IBA
08/2003
1Histone Deacetylase InhibitorsIBA
08/2003

Therapy/Procedure

4Drug Therapy (Chemotherapy)
12/2021 - 01/2003
3Therapeutics
01/2021 - 10/2016
3Transplantation
01/2020 - 07/2008
2Homologous Transplantation
01/2017 - 01/2016
1Induction Chemotherapy
12/2021
1Chemoradiotherapy
12/2020
1Cryotherapy (Therapy, Cold)
01/2020
1Radiotherapy
01/2020
1Blood Component Removal (Apheresis)
11/2017
1Time-to-Treatment
01/2016
1Microspheres (Microsphere)
08/2015